#term ID	term description	observed gene count	background gene count	strength	false discovery rate	matching proteins in your network (IDs)	matching proteins in your network (labels)
hsa05200	Pathways in cancer	25	517	0.75	2.59e-09	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000257430,9606.ENSP00000258341,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000288266,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000368104,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000419422,9606.ENSP00000478570	MAPK1,TGFB1,EPOR,IFNG,APC,LAMC1,CDH1,IGF1R,APPL1,EDNRA,PDGFB,STAT5A,PDGFA,PTGS2,PTEN,AR,BMP2,EDN1,JAK2,NFE2L2,BCL2,FGFR1,RHOA,AGTR1,VEGFA
hsa05206	MicroRNAs in cancer	15	160	1.03	4.52e-09	9606.ENSP00000215832,9606.ENSP00000216862,9606.ENSP00000257430,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000278616,9606.ENSP00000306124,9606.ENSP00000311005,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,CYP24A1,APC,THBS1,TIMP3,ATM,PRKCE,MAPK7,PDGFB,PDGFA,PTGS2,PTEN,BCL2,RHOA,VEGFA
hsa05418	Fluid shear stress and atherosclerosis	14	130	1.09	4.52e-09	9606.ENSP00000229135,9606.ENSP00000311005,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000346148,9606.ENSP00000346508,9606.ENSP00000351908,9606.ENSP00000362057,9606.ENSP00000363641,9606.ENSP00000368683,9606.ENSP00000380252,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	IFNG,MAPK7,PDGFB,CAV1,PRKAA1,PDGFA,MAP3K5,NOX1,TXN,EDN1,NFE2L2,BCL2,RHOA,VEGFA
hsa04151	PI3K-Akt signaling pathway	18	350	0.77	2.18e-07	9606.ENSP00000215832,9606.ENSP00000222139,9606.ENSP00000258341,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346148,9606.ENSP00000346508,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,EPOR,LAMC1,THBS1,IGF1R,ANGPT2,PDGFB,PRKAA1,PDGFA,SGK1,PTEN,JAK2,PDGFD,BCL2,FGFR1,NTF3,BDNF,VEGFA
hsa04933	AGE-RAGE signaling pathway in diabetic complications	11	98	1.11	2.18e-07	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000263317,9606.ENSP00000306124,9606.ENSP00000341208,9606.ENSP00000362057,9606.ENSP00000368683,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000419422,9606.ENSP00000478570	MAPK1,TGFB1,NOX4,PRKCE,STAT5A,NOX1,EDN1,JAK2,BCL2,AGTR1,VEGFA
hsa01521	EGFR tyrosine kinase inhibitor resistance	10	78	1.17	2.44e-07	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000331831,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000478570	MAPK1,IGF1R,PDGFB,GAS6,PDGFA,PTEN,JAK2,PDGFD,BCL2,VEGFA
hsa04010	MAPK signaling pathway	16	288	0.81	4.33e-07	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000248553,9606.ENSP00000268035,9606.ENSP00000311005,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000351908,9606.ENSP00000376865,9606.ENSP00000390651,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000401399,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,TGFB1,HSPB1,IGF1R,MAPK7,ANGPT2,PDGFB,PDGFA,MAP3K5,PDGFD,IRAK4,FGFR1,NTF3,MYD88,BDNF,VEGFA
hsa04015	Rap1 signaling pathway	13	202	0.87	1.97e-06	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000304767,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000358513,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,THBS1,CDH1,IGF1R,P2RY1,ANGPT2,PDGFB,PDGFA,CNR1,PDGFD,FGFR1,RHOA,VEGFA
hsa04350	TGF-beta signaling pathway	9	91	1.06	7.66e-06	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000347041,9606.ENSP00000364683,9606.ENSP00000368104,9606.ENSP00000400175,9606.ENSP00000478319	MAPK1,TGFB1,IFNG,THBS1,FMOD,BAMBI,BMP2,RHOA,GREM1
hsa04510	Focal adhesion	12	198	0.84	9.70e-06	9606.ENSP00000215832,9606.ENSP00000258341,9606.ENSP00000260356,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000339191,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,LAMC1,THBS1,IGF1R,PDGFB,CAV1,PDGFA,PTEN,PDGFD,BCL2,RHOA,VEGFA
hsa05215	Prostate cancer	9	96	1.03	9.70e-06	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000363822,9606.ENSP00000376865,9606.ENSP00000381185,9606.ENSP00000393312	MAPK1,IGF1R,PDGFB,PDGFA,PTEN,AR,PDGFD,BCL2,FGFR1
hsa05218	Melanoma	8	72	1.11	1.23e-05	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021,9606.ENSP00000376865,9606.ENSP00000393312	MAPK1,CDH1,IGF1R,PDGFB,PDGFA,PTEN,PDGFD,FGFR1
hsa05145	Toxoplasmosis	9	105	0.99	1.63e-05	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000258341,9606.ENSP00000292303,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399	MAPK1,TGFB1,IFNG,LAMC1,CCR5,JAK2,BCL2,IRAK4,MYD88
hsa04014	Ras signaling pathway	12	226	0.79	2.51e-05	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000383364,9606.ENSP00000393312,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303,9606.ENSP00000478570	MAPK1,IGF1R,ANGPT2,PDGFB,PDGFA,PDGFD,PLA2G2A,FGFR1,NTF3,RHOA,BDNF,VEGFA
hsa04668	TNF signaling pathway	9	112	0.97	2.51e-05	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000308208,9606.ENSP00000351671,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000368683,9606.ENSP00000403495,9606.ENSP00000474412	MAPK1,CXCL10,MMP14,CCL20,MAP3K5,PTGS2,EDN1,LTA,CCL5
hsa05205	Proteoglycans in cancer	11	196	0.81	3.92e-05	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000260356,9606.ENSP00000266085,9606.ENSP00000268035,9606.ENSP00000339191,9606.ENSP00000363827,9606.ENSP00000384262,9606.ENSP00000393312,9606.ENSP00000400175,9606.ENSP00000478570	MAPK1,TGFB1,THBS1,TIMP3,IGF1R,CAV1,HSPG2,HPSE,FGFR1,RHOA,VEGFA
hsa05140	Leishmaniasis	7	70	1.06	8.90e-05	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000390651,9606.ENSP00000401399	MAPK1,TGFB1,IFNG,PTGS2,JAK2,IRAK4,MYD88
hsa04928	Parathyroid hormone synthesis, secretion and action	8	103	0.95	9.97e-05	9606.ENSP00000215832,9606.ENSP00000216862,9606.ENSP00000308208,9606.ENSP00000362410,9606.ENSP00000369442,9606.ENSP00000381185,9606.ENSP00000393312,9606.ENSP00000400175	MAPK1,CYP24A1,MMP14,MAFB,KL,BCL2,FGFR1,RHOA
hsa04066	HIF-1 signaling pathway	8	106	0.94	0.00012	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000268035,9606.ENSP00000314897,9606.ENSP00000368683,9606.ENSP00000381185,9606.ENSP00000385834,9606.ENSP00000478570	MAPK1,IFNG,IGF1R,ANGPT2,EDN1,BCL2,TF,VEGFA
hsa04060	Cytokine-cytokine receptor interaction	12	282	0.69	0.00016	9606.ENSP00000221930,9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000355370,9606.ENSP00000368104,9606.ENSP00000403495,9606.ENSP00000474412	TGFB1,EPOR,IFNG,CCR5,CXCL10,CXCL11,CCL20,CXCL9,CNTF,BMP2,LTA,CCL5
hsa04722	Neurotrophin signaling pathway	8	114	0.91	0.00017	9606.ENSP00000215832,9606.ENSP00000311005,9606.ENSP00000351908,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000397297,9606.ENSP00000400175,9606.ENSP00000414303	MAPK1,MAPK7,MAP3K5,BCL2,IRAK4,NTF3,RHOA,BDNF
hsa01100	Metabolic pathways	29	1447	0.36	0.00036	9606.ENSP00000216075,9606.ENSP00000216862,9606.ENSP00000226279,9606.ENSP00000227868,9606.ENSP00000259407,9606.ENSP00000263774,9606.ENSP00000278840,9606.ENSP00000281382,9606.ENSP00000297785,9606.ENSP00000325548,9606.ENSP00000337332,9606.ENSP00000349860,9606.ENSP00000354511,9606.ENSP00000356438,9606.ENSP00000360247,9606.ENSP00000360250,9606.ENSP00000361021,9606.ENSP00000362463,9606.ENSP00000363973,9606.ENSP00000365777,9606.ENSP00000369442,9606.ENSP00000377192,9606.ENSP00000380365,9606.ENSP00000383232,9606.ENSP00000383364,9606.ENSP00000384262,9606.ENSP00000401720,9606.ENSP00000478253,9606.ENSP00000483018	MIOX,CYP24A1,CD38,PDHX,BAAT,NDUFS3,FADS2,PIGF,ALDH1A1,CNDP2,SIRT6,GFPT1,COMT,PTGS2,CYP2J2,ENTPD1,PTEN,GLO1,ALPL,MTHFR,KL,G6PD,RGN,GGT1,PLA2G2A,HPSE,GK,MTHFD1L,ABO
hsa04061	Viral protein interaction with cytokine and cytokine receptor	7	96	0.92	0.00045	9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000403495,9606.ENSP00000474412	CCR5,CXCL10,CXCL11,CCL20,CXCL9,LTA,CCL5
hsa04270	Vascular smooth muscle contraction	8	133	0.84	0.00045	9606.ENSP00000215832,9606.ENSP00000216181,9606.ENSP00000306124,9606.ENSP00000315011,9606.ENSP00000368683,9606.ENSP00000383364,9606.ENSP00000400175,9606.ENSP00000419422	MAPK1,MYH9,PRKCE,EDNRA,EDN1,PLA2G2A,RHOA,AGTR1
hsa05142	Chagas disease	7	99	0.91	0.00050	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000354782,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412	MAPK1,TGFB1,IFNG,CD247,IRAK4,MYD88,CCL5
hsa04620	Toll-like receptor signaling pathway	7	101	0.9	0.00054	9606.ENSP00000215832,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000354901,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412	MAPK1,CXCL10,CXCL11,CXCL9,IRAK4,MYD88,CCL5
hsa04062	Chemokine signaling pathway	9	186	0.75	0.00062	9606.ENSP00000215832,9606.ENSP00000292303,9606.ENSP00000305651,9606.ENSP00000306884,9606.ENSP00000351671,9606.ENSP00000354901,9606.ENSP00000371067,9606.ENSP00000400175,9606.ENSP00000474412	MAPK1,CCR5,CXCL10,CXCL11,CCL20,CXCL9,JAK2,RHOA,CCL5
hsa03320	PPAR signaling pathway	6	75	0.96	0.00085	9606.ENSP00000256104,9606.ENSP00000278840,9606.ENSP00000300055,9606.ENSP00000309757,9606.ENSP00000401720,9606.ENSP00000477707	FABP4,FADS2,PLIN1,LPL,GK,NR1H3
hsa04630	JAK-STAT signaling pathway	8	160	0.76	0.0012	9606.ENSP00000222139,9606.ENSP00000229135,9606.ENSP00000330382,9606.ENSP00000341208,9606.ENSP00000346508,9606.ENSP00000355370,9606.ENSP00000371067,9606.ENSP00000381185	EPOR,IFNG,PDGFB,STAT5A,PDGFA,CNTF,JAK2,BCL2
hsa04810	Regulation of actin cytoskeleton	9	209	0.7	0.0012	9606.ENSP00000215832,9606.ENSP00000216181,9606.ENSP00000257430,9606.ENSP00000330382,9606.ENSP00000339916,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000393312,9606.ENSP00000400175	MAPK1,MYH9,APC,PDGFB,LIMK2,PDGFA,PDGFD,FGFR1,RHOA
hsa05161	Hepatitis B	8	159	0.76	0.0012	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000341208,9606.ENSP00000363827,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399	MAPK1,TGFB1,STAT5A,HSPG2,JAK2,BCL2,IRAK4,MYD88
hsa05210	Colorectal cancer	6	82	0.93	0.0012	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000257430,9606.ENSP00000288266,9606.ENSP00000381185,9606.ENSP00000400175	MAPK1,TGFB1,APC,APPL1,BCL2,RHOA
hsa05164	Influenza A	8	165	0.75	0.0013	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000265333,9606.ENSP00000305651,9606.ENSP00000371067,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000474412	MAPK1,IFNG,VDAC1,CXCL10,JAK2,IRAK4,MYD88,CCL5
hsa05152	Tuberculosis	8	168	0.74	0.0014	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000371067,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000401399	MAPK1,TGFB1,IFNG,JAK2,BCL2,IRAK4,RHOA,MYD88
hsa04068	FoxO signaling pathway	7	127	0.8	0.0016	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000268035,9606.ENSP00000278616,9606.ENSP00000346148,9606.ENSP00000356832,9606.ENSP00000361021	MAPK1,TGFB1,IGF1R,ATM,PRKAA1,SGK1,PTEN
hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	6	88	0.89	0.0016	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000354782,9606.ENSP00000361021,9606.ENSP00000371067,9606.ENSP00000401399	MAPK1,IFNG,CD247,PTEN,JAK2,MYD88
hsa04371	Apelin signaling pathway	7	131	0.79	0.0017	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000300055,9606.ENSP00000306124,9606.ENSP00000346148,9606.ENSP00000419422,9606.ENSP00000475344	MAPK1,CDH1,PLIN1,PRKCE,PRKAA1,AGTR1,APLNR
hsa04621	NOD-like receptor signaling pathway	8	174	0.72	0.0017	9606.ENSP00000215832,9606.ENSP00000265333,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412	MAPK1,VDAC1,TXN,BCL2,IRAK4,RHOA,MYD88,CCL5
hsa04657	IL-17 signaling pathway	6	92	0.88	0.0018	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000305651,9606.ENSP00000311005,9606.ENSP00000351671,9606.ENSP00000356438	MAPK1,IFNG,CXCL10,MAPK7,CCL20,PTGS2
hsa04064	NF-kappa B signaling pathway	6	101	0.83	0.0028	9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399,9606.ENSP00000403495	ATM,PTGS2,BCL2,IRAK4,MYD88,LTA
hsa04659	Th17 cell differentiation	6	101	0.83	0.0028	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000371067	MAPK1,TGFB1,IFNG,STAT5A,CD247,JAK2
hsa04020	Calcium signaling pathway	8	193	0.68	0.0029	9606.ENSP00000226279,9606.ENSP00000265333,9606.ENSP00000315011,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000419422,9606.ENSP00000445772	CD38,VDAC1,EDNRA,PDGFB,PDGFA,PDGFD,AGTR1,LTB4R2
hsa04520	Adherens junction	5	67	0.93	0.0031	9606.ENSP00000215832,9606.ENSP00000261769,9606.ENSP00000268035,9606.ENSP00000393312,9606.ENSP00000400175	MAPK1,CDH1,IGF1R,FGFR1,RHOA
hsa04931	Insulin resistance	6	107	0.81	0.0034	9606.ENSP00000306124,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000349860,9606.ENSP00000361021,9606.ENSP00000477707	PRKCE,PRKAA1,SREBF1,GFPT1,PTEN,NR1H3
hsa05230	Central carbon metabolism in cancer	5	69	0.92	0.0034	9606.ENSP00000215832,9606.ENSP00000337332,9606.ENSP00000361021,9606.ENSP00000377192,9606.ENSP00000393312	MAPK1,SIRT6,PTEN,G6PD,FGFR1
hsa01524	Platinum drug resistance	5	70	0.91	0.0035	9606.ENSP00000013807,9606.ENSP00000215832,9606.ENSP00000278616,9606.ENSP00000351908,9606.ENSP00000381185	ERCC1,MAPK1,ATM,MAP3K5,BCL2
hsa05170	Human immunodeficiency virus 1 infection	8	204	0.65	0.0037	9606.ENSP00000215832,9606.ENSP00000278616,9606.ENSP00000292303,9606.ENSP00000339916,9606.ENSP00000354782,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399	MAPK1,ATM,CCR5,LIMK2,CD247,BCL2,IRAK4,MYD88
hsa05214	Glioma	5	72	0.9	0.0037	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000361021	MAPK1,IGF1R,PDGFB,PDGFA,PTEN
hsa04024	cAMP signaling pathway	8	208	0.65	0.0040	9606.ENSP00000215832,9606.ENSP00000245479,9606.ENSP00000315011,9606.ENSP00000356213,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000400175,9606.ENSP00000414303	MAPK1,SOX9,EDNRA,VIP,EDN1,NPY,RHOA,BDNF
hsa05219	Bladder cancer	4	41	1.05	0.0040	9606.ENSP00000215832,9606.ENSP00000260356,9606.ENSP00000261769,9606.ENSP00000478570	MAPK1,THBS1,CDH1,VEGFA
hsa04071	Sphingolipid signaling pathway	6	116	0.77	0.0044	9606.ENSP00000215832,9606.ENSP00000306124,9606.ENSP00000351908,9606.ENSP00000361021,9606.ENSP00000381185,9606.ENSP00000400175	MAPK1,PRKCE,MAP3K5,PTEN,BCL2,RHOA
hsa04080	Neuroactive ligand-receptor interaction	10	330	0.54	0.0049	9606.ENSP00000304767,9606.ENSP00000315011,9606.ENSP00000356213,9606.ENSP00000358513,9606.ENSP00000363596,9606.ENSP00000368683,9606.ENSP00000384364,9606.ENSP00000419422,9606.ENSP00000445772,9606.ENSP00000475344	P2RY1,EDNRA,VIP,CNR1,CNR2,EDN1,NPY,AGTR1,LTB4R2,APLNR
hsa05131	Shigellosis	8	218	0.63	0.0050	9606.ENSP00000215832,9606.ENSP00000265333,9606.ENSP00000278616,9606.ENSP00000306124,9606.ENSP00000381185,9606.ENSP00000400175,9606.ENSP00000401399,9606.ENSP00000474412	MAPK1,VDAC1,ATM,PRKCE,BCL2,RHOA,MYD88,CCL5
hsa05144	Malaria	4	46	1.0	0.0056	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000260356,9606.ENSP00000401399	TGFB1,IFNG,THBS1,MYD88
hsa04979	Cholesterol metabolism	4	48	0.98	0.0064	9606.ENSP00000200676,9606.ENSP00000265333,9606.ENSP00000309757,9606.ENSP00000321334	CETP,VDAC1,LPL,LPA
hsa05323	Rheumatoid arthritis	5	85	0.83	0.0065	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000351671,9606.ENSP00000474412,9606.ENSP00000478570	TGFB1,IFNG,CCL20,CCL5,VEGFA
hsa04540	Gap junction	5	87	0.82	0.0071	9606.ENSP00000215832,9606.ENSP00000311005,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865	MAPK1,MAPK7,PDGFB,PDGFA,PDGFD
hsa04658	Th1 and Th2 cell differentiation	5	87	0.82	0.0071	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000341208,9606.ENSP00000354782,9606.ENSP00000371067	MAPK1,IFNG,STAT5A,CD247,JAK2
hsa05010	Alzheimer disease	10	355	0.51	0.0073	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000263317,9606.ENSP00000263774,9606.ENSP00000265333,9606.ENSP00000309757,9606.ENSP00000351908,9606.ENSP00000356438,9606.ENSP00000362057,9606.ENSP00000418525	MAPK1,APC,NOX4,NDUFS3,VDAC1,LPL,MAP3K5,PTGS2,NOX1,MME
hsa05167	Kaposi sarcoma-associated herpesvirus infection	7	187	0.63	0.0083	9606.ENSP00000215832,9606.ENSP00000292303,9606.ENSP00000314897,9606.ENSP00000330382,9606.ENSP00000356438,9606.ENSP00000371067,9606.ENSP00000478570	MAPK1,CCR5,ANGPT2,PDGFB,PTGS2,JAK2,VEGFA
hsa04923	Regulation of lipolysis in adipocytes	4	54	0.93	0.0086	9606.ENSP00000256104,9606.ENSP00000300055,9606.ENSP00000356438,9606.ENSP00000384364	FABP4,PLIN1,PTGS2,NPY
hsa04550	Signaling pathways regulating pluripotency of stem cells	6	140	0.69	0.0091	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000268035,9606.ENSP00000302630,9606.ENSP00000371067,9606.ENSP00000393312	MAPK1,APC,IGF1R,ONECUT1,JAK2,FGFR1
hsa04370	VEGF signaling pathway	4	57	0.91	0.0101	9606.ENSP00000215832,9606.ENSP00000248553,9606.ENSP00000356438,9606.ENSP00000478570	MAPK1,HSPB1,PTGS2,VEGFA
hsa04950	Maturity onset diabetes of the young	3	26	1.12	0.0101	9606.ENSP00000302630,9606.ENSP00000312987,9606.ENSP00000480291	ONECUT1,HNF4A,HNF1B
hsa05213	Endometrial cancer	4	57	0.91	0.0101	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000361021	MAPK1,APC,CDH1,PTEN
hsa04072	Phospholipase D signaling pathway	6	147	0.67	0.0108	9606.ENSP00000215832,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865,9606.ENSP00000400175,9606.ENSP00000419422	MAPK1,PDGFB,PDGFA,PDGFD,RHOA,AGTR1
hsa04932	Non-alcoholic fatty liver disease	6	148	0.67	0.0110	9606.ENSP00000221930,9606.ENSP00000263774,9606.ENSP00000346148,9606.ENSP00000348069,9606.ENSP00000351908,9606.ENSP00000477707	TGFB1,NDUFS3,PRKAA1,SREBF1,MAP3K5,NR1H3
hsa04921	Oxytocin signaling pathway	6	149	0.67	0.0112	9606.ENSP00000215832,9606.ENSP00000226279,9606.ENSP00000311005,9606.ENSP00000346148,9606.ENSP00000356438,9606.ENSP00000400175	MAPK1,CD38,MAPK7,PRKAA1,PTGS2,RHOA
hsa00590	Arachidonic acid metabolism	4	61	0.88	0.0116	9606.ENSP00000356438,9606.ENSP00000360247,9606.ENSP00000383232,9606.ENSP00000383364	PTGS2,CYP2J2,GGT1,PLA2G2A
hsa04150	mTOR signaling pathway	6	151	0.66	0.0116	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000346148,9606.ENSP00000356832,9606.ENSP00000361021,9606.ENSP00000400175	MAPK1,IGF1R,PRKAA1,SGK1,PTEN,RHOA
hsa05166	Human T-cell leukemia virus 1 infection	7	211	0.58	0.0136	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000265333,9606.ENSP00000278616,9606.ENSP00000341208,9606.ENSP00000361021,9606.ENSP00000403495	MAPK1,TGFB1,VDAC1,ATM,STAT5A,PTEN,LTA
hsa05211	Renal cell carcinoma	4	66	0.84	0.0146	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000330382,9606.ENSP00000478570	MAPK1,TGFB1,PDGFB,VEGFA
hsa05225	Hepatocellular carcinoma	6	160	0.64	0.0147	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000257430,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000380252	MAPK1,TGFB1,APC,IGF1R,PTEN,NFE2L2
hsa04022	cGMP-PKG signaling pathway	6	162	0.63	0.0154	9606.ENSP00000215832,9606.ENSP00000265333,9606.ENSP00000306124,9606.ENSP00000315011,9606.ENSP00000400175,9606.ENSP00000419422	MAPK1,VDAC1,PRKCE,EDNRA,RHOA,AGTR1
hsa05100	Bacterial invasion of epithelial cells	4	70	0.82	0.0171	9606.ENSP00000261769,9606.ENSP00000339191,9606.ENSP00000352264,9606.ENSP00000400175	CDH1,CAV1,CD2AP,RHOA
hsa04115	p53 signaling pathway	4	72	0.81	0.0186	9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000361021,9606.ENSP00000381185	THBS1,ATM,PTEN,BCL2
hsa04714	Thermogenesis	7	229	0.55	0.0193	9606.ENSP00000263774,9606.ENSP00000300055,9606.ENSP00000337332,9606.ENSP00000346148,9606.ENSP00000351908,9606.ENSP00000358513,9606.ENSP00000393312	NDUFS3,PLIN1,SIRT6,PRKAA1,MAP3K5,CNR1,FGFR1
hsa05133	Pertussis	4	74	0.79	0.0197	9606.ENSP00000215832,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000401399	MAPK1,IRAK4,RHOA,MYD88
hsa05143	African trypanosomiasis	3	36	0.98	0.0197	9606.ENSP00000229135,9606.ENSP00000317674,9606.ENSP00000401399	IFNG,APOL1,MYD88
hsa00430	Taurine and hypotaurine metabolism	2	11	1.32	0.0227	9606.ENSP00000259407,9606.ENSP00000383232	BAAT,GGT1
hsa04140	Autophagy - animal	5	130	0.65	0.0262	9606.ENSP00000215832,9606.ENSP00000268035,9606.ENSP00000346148,9606.ENSP00000361021,9606.ENSP00000381185	MAPK1,IGF1R,PRKAA1,PTEN,BCL2
hsa05169	Epstein-Barr virus infection	6	193	0.55	0.0313	9606.ENSP00000305651,9606.ENSP00000354782,9606.ENSP00000360250,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000401399	CXCL10,CD247,ENTPD1,BCL2,IRAK4,MYD88
hsa04211	Longevity regulating pathway	4	87	0.72	0.0322	9606.ENSP00000268035,9606.ENSP00000288266,9606.ENSP00000346148,9606.ENSP00000369442	IGF1R,APPL1,PRKAA1,KL
hsa04512	ECM-receptor interaction	4	88	0.72	0.0330	9606.ENSP00000258341,9606.ENSP00000260356,9606.ENSP00000355361,9606.ENSP00000363827	LAMC1,THBS1,CD47,HSPG2
hsa05165	Human papillomavirus infection	8	325	0.45	0.0331	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000258341,9606.ENSP00000260356,9606.ENSP00000278616,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000478570	MAPK1,APC,LAMC1,THBS1,ATM,PTGS2,PTEN,VEGFA
hsa04930	Type II diabetes mellitus	3	46	0.88	0.0338	9606.ENSP00000215832,9606.ENSP00000306124,9606.ENSP00000345708	MAPK1,PRKCE,KCNJ11
hsa04640	Hematopoietic cell lineage	4	91	0.7	0.0356	9606.ENSP00000222139,9606.ENSP00000226279,9606.ENSP00000310036,9606.ENSP00000418525	EPOR,CD38,CD34,MME
hsa05222	Small cell lung cancer	4	92	0.7	0.0361	9606.ENSP00000258341,9606.ENSP00000356438,9606.ENSP00000361021,9606.ENSP00000381185	LAMC1,PTGS2,PTEN,BCL2
hsa05226	Gastric cancer	5	144	0.6	0.0361	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000257430,9606.ENSP00000261769,9606.ENSP00000381185	MAPK1,TGFB1,APC,CDH1,BCL2
hsa05224	Breast cancer	5	145	0.6	0.0363	9606.ENSP00000215832,9606.ENSP00000257430,9606.ENSP00000268035,9606.ENSP00000361021,9606.ENSP00000393312	MAPK1,APC,IGF1R,PTEN,FGFR1
hsa04217	Necroptosis	5	149	0.59	0.0396	9606.ENSP00000229135,9606.ENSP00000265333,9606.ENSP00000341208,9606.ENSP00000371067,9606.ENSP00000381185	IFNG,VDAC1,STAT5A,JAK2,BCL2
hsa04218	Cellular senescence	5	150	0.58	0.0396	9606.ENSP00000215832,9606.ENSP00000221930,9606.ENSP00000265333,9606.ENSP00000278616,9606.ENSP00000361021	MAPK1,TGFB1,VDAC1,ATM,PTEN
hsa04913	Ovarian steroidogenesis	3	50	0.84	0.0396	9606.ENSP00000268035,9606.ENSP00000356438,9606.ENSP00000360247	IGF1R,PTGS2,CYP2J2
hsa05132	Salmonella infection	6	209	0.52	0.0396	9606.ENSP00000215832,9606.ENSP00000363641,9606.ENSP00000381185,9606.ENSP00000390651,9606.ENSP00000400175,9606.ENSP00000401399	MAPK1,TXN,BCL2,IRAK4,RHOA,MYD88
hsa05231	Choline metabolism in cancer	4	96	0.68	0.0396	9606.ENSP00000215832,9606.ENSP00000330382,9606.ENSP00000346508,9606.ENSP00000376865	MAPK1,PDGFB,PDGFA,PDGFD
hsa04972	Pancreatic secretion	4	98	0.67	0.0411	9606.ENSP00000226279,9606.ENSP00000383364,9606.ENSP00000400175,9606.ENSP00000419313	CD38,PLA2G2A,RHOA,TRPC1
hsa05146	Amoebiasis	4	100	0.66	0.0435	9606.ENSP00000221930,9606.ENSP00000229135,9606.ENSP00000248553,9606.ENSP00000258341	TGFB1,IFNG,HSPB1,LAMC1
hsa04530	Tight junction	5	156	0.57	0.0442	9606.ENSP00000216181,9606.ENSP00000306124,9606.ENSP00000346148,9606.ENSP00000351908,9606.ENSP00000400175	MYH9,PRKCE,PRKAA1,MAP3K5,RHOA
hsa04660	T cell receptor signaling pathway	4	101	0.66	0.0442	9606.ENSP00000215832,9606.ENSP00000229135,9606.ENSP00000354782,9606.ENSP00000400175	MAPK1,IFNG,CD247,RHOA
hsa05163	Human cytomegalovirus infection	6	218	0.5	0.0443	9606.ENSP00000215832,9606.ENSP00000292303,9606.ENSP00000356438,9606.ENSP00000400175,9606.ENSP00000474412,9606.ENSP00000478570	MAPK1,CCR5,PTGS2,RHOA,CCL5,VEGFA
